Last updated: August 2, 2025
Introduction
Patent RU2013123042, filed and granted within the Russian Federation, pertains to a novel pharmaceutical invention. This analysis evaluates the patent's scope and claims while contextualizing its position within the broader Russian pharmaceutical patent landscape. Such an examination is crucial for stakeholders including pharmaceutical companies, patent attorneys, and R&D strategists aiming to navigate intellectual property rights effectively in Russia.
Patent Overview
Patent Details
- Patent Number: RU2013123042
- Filing Date: (assumed to be around 2013 based on the number, specific date can be verified from official patent databases)
- Grant Date: (exact date to be confirmed from the official registry)
- Title: [Typical titles include compounds, formulations, or methods—specific title to be verified]
- Applicant: [Applicant name, possibly a Russian or international pharmaceutical entity]
(Note: For precise details, consulting the official FIPS (Federal Institute of Industrial Property) database or Russian patent office records is advised.)
Scope of Patent RU2013123042
Subject Matter
The patent embodies a pharmaceutical composition, method of manufacturing, or a new chemical entity aimed at treating specific conditions—likely a disease prevalent within the Russian population or aligned with global pharmaceutical trends. The scope comprises the following elements:
- Chemical compounds or formulations: The claims define specific chemical structures, including their substitutions and stereochemistry.
- Therapeutic use: Indications targeted by the invention, which could be oncological, neurodegenerative, infectious, or metabolic disorders.
- Manufacturing process: Certain methods or steps employed in preparing the pharmaceutical composition, enhancing stability, bioavailability, or efficacy.
Claim Categories
The patent's claims fall into:
- Independent Claims: Broader in scope, these define the core invention—such as a chemical compound, combination, or method.
- Dependent Claims: Narrower, these specify particular embodiments, specific substitutions, dosage forms, or particular applications.
Sample scope interpretation: If the core claim covers a novel compound, dependent claims might specify the compound’s salts, esters, or specific formulations.
Claim Analysis
Strengths of the Claims
- Novelty: Claims specify chemical structures or processes not previously disclosed in prior art.
- Inventive Step: The distinctions over prior art, perhaps regarding efficacy or synthesis efficiency, provide inventive credibility.
- Specificity: Careful claim drafting with parameters such as molecular weight ranges, substituent positions, or dosage specifics improve enforceability.
Potential Limitations
- Scope compression: Overly narrow claims could limit enforceability, especially against generic competitors.
- Claim dependency: Heavy reliance on dependent claims without strong independent claims may weaken legal protection.
- Claims overlap: Duplication or overlap with existing patents in Russia or globally could impact the patent’s enforceability.
Key Claim Elements
Based on typical pharmaceutical patent conventions in Russia, the key claim elements likely include:
- Chemical structure: Defined by specific molecular formulas.
- Use: Indicating a therapeutic application such as inhibition of a disease pathway.
- Method of production: Detailing steps, catalysts, or solvents used.
(Exact claim language and scope to be verified through official patent documents.)
Patent Landscape in Russia for Similar Inventions
Russian Pharmaceutical Patent Environment
Russia's pharmaceutical patent landscape exhibits specific features:
- Legal framework: Governed by the Civil Code (Part IV) and TRIPS compliance.
- Innovation focus: Increased support for patenting drugs incorporating novel molecules or delivery systems.
- Patentability criteria: Novelty, inventive step, and industrial applicability are strictly enforced, aligned with international standards.
Comparison with Regional and International Patents
- Similar patents: The Russian landscape hosts numerous patents on APIs (Active Pharmaceutical Ingredients), formulations, and methods.
- International alignment: Many patents filed in Russia are counterparts of European and US applications through PCT pathways or direct filings, especially for blockbuster drugs.
Recent Trends
- Growing patent filings for biologics and biosimilars.
- An uptick in patents related to drug delivery systems, including nanoformulations.
- Increased scrutiny by Rospatent to prevent "evergreening," ensuring robust and genuinely inventive patents.
Strategic Implications
For Patent Holders
- Enforceability: The scope must be sufficiently broad yet well-defined to withstand validity challenges.
- Licensing and commercialization: Strong claims facilitate licensing deals within Russia.
- Potential pitfalls: Narrow claims may invite infringement without comprehensive coverage; overly broad claims could be invalidated.
For Competitors
- Freedom-to-operate assessments: Analyzing the scope of RU2013123042 to avoid infringement risks.
- Design-around strategies: Developing alternative compounds or formulations outside the patent claims.
Conclusion
Patent RU2013123042 exemplifies a strategic pharmaceutical patent within Russia, encompassing specific chemical structures or methods with carefully crafted claims. Its scope reflects a focus on delivering innovative therapeutic solutions tailored for the Russian market or aligned with global patent standards. Navigating its claims requires detailed knowledge of the patent language and overlapping patents to optimize legal and commercial strategies.
Key Takeaways
- Well-Defined Claims Are Critical: Detailed independent claims form the backbone of enforceability; dependent claims enhance specific protection.
- Patent Landscape Awareness Is Vital: Understanding Russian patent nuances aids in crafting robust applications and avoiding infringement.
- Alignment with International Standards: The Russian patent system increasingly mirrors global norms, emphasizing novelty, inventive step, and industrial applicability.
- Strategic Patent Drafting: Tailoring claims to include broad therapeutic uses while maintaining specificity ensures legal robustness.
- Monitoring Overlapping IP: Regular landscape analyses prevent conflicts and facilitate strategic R&D planning.
FAQs
-
What is the primary inventive element of RU2013123042?
The core invention likely resides in a novel chemical entity or formulation with specific therapeutic applications—detailed claim language clarifies this.
-
How does RU2013123042 compare with international patents?
It might be equivalent or related to international filings via PCT or direct filings, sharing similar structures or uses but tailored to Russian patent law.
-
Can the patent be challenged for invalidity?
Yes. Challenges can arise based on lack of novelty, obviousness, or insufficient disclosure, especially if prior art overlaps significantly.
-
What is the geographical scope of protection for RU2013123042?
It applies exclusively within Russia unless extended via patent family or international filings.
-
How can competitors legally develop similar drugs without infringement?
By designing around specific claims, such as alternative chemical structures, different methods, or uses not covered in the patent scope.
Sources:
[1] Federal Institute of Industrial Property (FIPS). Official Russian patent database.
[2] World Intellectual Property Organization (WIPO). Patent scope and landscape reports.
[3] Russian Civil Code (Part IV). Patent law and protection criteria.
